549
Views
29
CrossRef citations to date
0
Altmetric
Original Articles

Profiles of Medicinal Cannabis Patients Attending Compassion Centers in Rhode Island

, Ph.D., , Ph.D., , M.D.M.H.A., , B.S.N. & , M.D.

REFERENCES

  • Abrams, D.I.; Couey, P.; Shade, S.B.; Kelly, M.E. & Benowitz, N.L. 2011. Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther 90 (6): 844–51.
  • Bachhuber, M.A.; Saloner, B.; Cunningham, C.O. & Barry, C.L. 2014. Medical cannabis laws and opioid analgesic oversode mortality in the United States, 1999–2010. JAMA Intern Med 174 (10): 1668–73. 2014.
  • Ben Amar, M. 2006. Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol 105 (1–2): 1–25.
  • Bonn-Miller, M.O.; Boden, M.T.; Bucossi, M.M. & Babson, K.A. 2014. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am J Drug Alcohol Abuse 40 (1): 23–30.
  • Bottorff, J.L.; Bissell, L.J.; Balneaves, L.G.; Oliffe, J.L.; Capler, N.R. & Buxton, J. 2013. Perceptions of cannabis as a stigmatized medicine: A qualitative descriptive study. Harm Reduct J 10: 2.
  • Carter, G.T.; Flanagan, A.M.; Earleywine, M.; Abrams, D.I.; Aggarwal, S.K. & Grinspoon, L. 2011. Cannabis in palliative medicine: Improving care and reducing opioid-related morbidity. Am J Hosp Palliat Care 28 (5): 297–303.
  • Hazekamp, A.; Ware, M.A.; Muller-Vahl, K.R.; Abrams, D. & Grotenhermen, F. 2013. The medicinal use of cannabis and cannabinoids: An international cross-sectional survey on administration forms. J Psychoactive Drugs 45 (3): 199–210.
  • Ilgen, M.A.; Bohnert, K.; Kleinberg, F.; Jannausch, M.; Bohnert, A.S.; Walton, M. & Blow, F.C. 2013. Characteristics of adults seeking medical marijuana certification. Drug Alcohol Depend 132 (3): 654–9.
  • Johnson, J.R.; Lossignol, D.; Burnell-Nugent, M. & Fallon, M.T. 2013. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manage 46 (2): 207–18.
  • Koppel, B.S.; Brust, J.C.; Fife, T.; Bronstein, J.; Youssof, S.; Gronseth, G. & Gloss, D. 2014. Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 82 (17): 1556–63.
  • Nunberg, H.; Kilmer, B.; Pacula, R.L. & Burgdorf, J. 2011. An analysis of applicants presenting to a medical marijuana specialty practice in California. J Drug Policy Anal 4 (1) : 1–9.
  • Pain Management of Rhode Island. 2014 Rhode Island Medical Marijuana Act Available at: http://rhode-island.medicalmarijuana.net/
  • Rahn, E.J. & Hohmann, A.G. 2009. Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside. Neurotherapeutics 6 (4): 713–37.
  • Reinarman, C.; Nunberg, H.; Lanthier, F. & Heddleston, T. 2011. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. J Psychoactive Drugs 43 (2): 128–35.
  • Rhode Island Patient Advocacy Coalition (RIPAC). 2013. Current Status of Compassion Centers in Rhode Island Available at: http://ripatients.org/compassioncenters.html
  • Riskcowski, J.R. 2014. Associations of socioeconomic position and pain prevalence in the United States: Findings from the National Health and Nutrition Examination Survey. Pain Medicine 15 (9): 1508–21.
  • Sacks, S.; Melnick, G.; Coen, C.; Banks, S.; Friedmann, P.D.; Grella, C.; Knight, K. & Zlotnick, C. 2007. CJDATS co-occurring disorders screening instrument (CODSI) for mental disorders (MD): A validation Study. Crim Justice Behav 34 (9): 1198–1216.
  • Shi, Q.; Wang, X.S.; Mendoza, T.R.; Pandya, K.J. & Cleeland, C.S. 2009. Assessing persistent cancer pain: A comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage 37 (2): 168–74.
  • State of Rhode Island Department of Health (Health). 2013 Fatal drug overdoses. Available at: http://www.health.ri.gov/data/death/drugoverdoses/
  • Subbaraman, M.S. 2013. Can cannabis be considered a substitute medication for alcohol? Alcohol Alcohol. 49 (3): 292–98.
  • Ware, M.A.; Wang, T.; Shapiro, S.; Robinson, A.; Ducruet, T.; Huynh, T.; Gamsa, A.; Bennett, G.J. & Collet, J.P. 2010. Smoked cannabis for chronic neuropathic pain: A randomized controlled trial. CMAJ 182 (14): E694–701.
  • Yokell, M.A.; Green, T.C.; Bowman, S.; McKenzie, M. & Rich, J.D. 2011. Opioid overdose prevention and naloxone distribution in Rhode Island. Med Health R I 94 (8): 240–2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.